GENSIGHT BIOLOGICS SA (SIGHT.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:SIGHT - FR0013183985 - Common Stock
0.101 EUR
0 (-0.59%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.12M | -14.00M | -26.22M | -27.63M | -28.62M | |||
| Depreciation Amortization | 658.00K | 1.06M | 2.18M | 1.06M | 928.00K | |||
| Change In Working Capital | 5.84M | 873.00K | 2.46M | -3.92M | 4.84M | |||
| Interest Paid | 437.00K | 278.00K | 368.00K | 1.87M | 835.00K | |||
| Other non cash items | 566.00K | -868.00K | -3.08M | -3.27M | 5.71M | |||
| OPERATING CASH FLOW | -8.05M | -12.94M | -24.66M | -33.75M | -17.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -1.00K | -10.00K | -252.00K | -32.00K | |||
| Other Investing Activity | -48.00K | 18.00K | 219.00K | 424.00K | 16.00K | |||
| INVESTING CASH FLOW | -48.00K | 17.00K | 209.00K | 172.00K | -16.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.84M | -2.90M | 12.31M | 2.12M | -3.65M | |||
| Stock Issued/Repurchased | 5.00M | 16.71M | 3.92M | -155.00K | 28.23M | |||
| Other Financing Activity | -439.00K | -278.00K | -368.00K | -1.87M | -836.00K | |||
| FINANCING CASH FLOW | 1.72M | 13.54M | 15.86M | 95.00K | 23.74M | |||
| Exchange Rate Effect | -289.00K | -293.00K | 119.00K | -193.00K | -238.00K | |||
| CHANGE IN CASH | -6.67M | 329.00K | -8.48M | -33.68M | 6.35M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.05M | -12.94M | -24.66M | -33.75M | -17.14M | |||
| Capital Expenditure | 0.00 | -1.00K | -10.00K | -252.00K | -32.00K | |||
| FREE CASH FLOW | -8.05M | -12.94M | -24.67M | -34.01M | -17.17M | |||
All data in EUR